MSI2 and neoplasm: The expression of Musashi-2 was negatively correlated with anti-inflammatory IL-10 (p =1.74e-10, cor =-0.27), the cellular response to hypoxia (p =2.22e-23, cor =-0.41), P53 signaling (p =7.75e-15, cor =-0.33), tumor proliferation (p =4.24e-17, cor =-0.35), angiogenesis (p =2.62e-12, cor =-0.30) and apoptosis (p =8.51e-11, cor =-0.28) (Figures S3A–F).